ADIPOQ and Huntington disease: However, in large-scale studies, an increased risk of CV events, particularly higher risks of sudden death and stroke, have been observed in HD patients with higher baseline adiponectin levels14, 15; moreover, higher adiponectin levels were independently associated with a three-fold higher risk of death in HD patients16.